The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Broussard, S. R.
Right arrow Articles by Kelley, K. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Broussard, S. R.
Right arrow Articles by Kelley, K. W.
The Journal of Immunology, 2004, 172: 7713-7720.
Copyright © 2004 by The American Association of Immunologists

IL-1{beta} Impairs Insulin-Like Growth Factor I-Induced Differentiation and Downstream Activation Signals of the Insulin-Like Growth Factor I Receptor in Myoblasts1

Suzanne R. Broussard2,*, Robert H. McCusker*, Jan E. Novakofski{dagger}, Klemen Strle*, Wen Hong Shen*, Rodney W. Johnson{ddagger}, Robert Dantzer§ and Keith W. Kelley*

* Laboratories of Immunophysiology, {dagger} Developmental Endocrinology, and {ddagger} Integrative Biology, Department of Animal Sciences, University of Illinois, Urbana-Champaign, Urbana, IL 61801; and § Integrative Neurobiology, FRE, Centre National de la Recherche Scientifique, Unité Mixte de Recherche Institut National de la Recherche Agronomique, Institut François Magendie des Neurosciences, Bordeaux, France

Proinflammatory cytokines are elevated in disorders characterized by muscle wasting and weakness, such as inflammatory myopathies and AIDS wasting. We recently demonstrated that TNF-{alpha} impairs the ability of insulin-like growth factor (IGF)-I to promote protein synthesis in muscle precursor cells. In this study we extend these findings by showing that low concentrations of IL-1{beta} impair IGF-I-dependent differentiation of myoblasts, as assessed by expression of the muscle specific protein, myosin heavy chain. In the absence of exogenous IGF-I, IL-1{beta} (1 ng/ml) did not impair muscle cell development. However, in the presence of IGF-I, 100-fold lower concentrations of IL-1{beta} (0.01 ng/ml) significantly suppressed myoblast differentiation, protein synthesis, and myogenin expression. Increasing IL-1{beta} to 1 ng/ml completely blocked the anabolic actions of IGF-I in murine C2C12 myoblasts. Similarly, IL-1{beta} inhibited IGF-I-stimulated protein synthesis in primary porcine myoblasts. IL-1{beta} impaired the actions of IGF-I at a point distal to the IGF receptor, and this was not due to IL-1{beta}-induced cell death. Instead, IL-1{beta} inhibited the ability of IGF-I to phosphorylate tyrosine residues on both of its downstream docking proteins, insulin receptor substrate 1 and insulin receptor substrate 2. These data establish that physiological concentrations of IL-1{beta} block the ability of IGF-I to promote protein synthesis, leading to reduced expression of the myogenic transcription factor, myogenin, and the subsequent development of more mature differentiated cells that express myosin heavy chain. Collectively, the results are consistent with the notion that very low concentrations of IL-1{beta} significantly impair myogenesis, but they are unable to do so in the absence of the growth factor IGF-I.




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
J. Petremand, N. Bulat, A.-C. Butty, C. Poussin, S. Rutti, K. Au, S. Ghosh, V. Mooser, B. Thorens, J.-Y. Yang, et al.
Involvement of 4E-BP1 in the Protection Induced by HDLs on Pancreatic {beta}-Cells
Mol. Endocrinol., October 1, 2009; 23(10): 1572 - 1586.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
W. Li, J. S. Moylan, M. A. Chambers, J. Smith, and M. B. Reid
Interleukin-1 stimulates catabolism in C2C12 myotubes
Am J Physiol Cell Physiol, January 1, 2009; 297(3): C706 - C714.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. Schmidt, K. Barthel, A. Wrede, M. Salajegheh, M. Bahr, and M. C. Dalakas
Interrelation of inflammation and APP in sIBM: IL-1{beta} induces accumulation of {beta}-amyloid in skeletal muscle
Brain, May 1, 2008; 131(5): 1228 - 1240.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. Strle, R. H. McCusker, R. W. Johnson, S. M. Zunich, R. Dantzer, and K. W. Kelley
Prototypical anti-inflammatory cytokine IL-10 prevents loss of IGF-I-induced myogenin protein expression caused by IL-1{beta}
Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E709 - E718.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
J. A. Carroll
Bidirectional communication: Growth and immunity in domestic livestock
J Anim Sci, April 1, 2008; 86(14_suppl): E126 - E137.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. Dogra, H. Changotra, N. Wedhas, X. Qin, J. E. Wergedal, and A. Kumar
TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine
FASEB J, June 1, 2007; 21(8): 1857 - 1869.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
L. Arnold, A. Henry, F. Poron, Y. Baba-Amer, N. van Rooijen, A. Plonquet, R. K. Gherardi, and B. Chazaud
Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis
J. Exp. Med., May 14, 2007; 204(5): 1057 - 1069.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Strle, S. R. Broussard, R. H. McCusker, W.-H. Shen, J. M. LeCleir, R. W. Johnson, G. G. Freund, R. Dantzer, and K. W. Kelley
C-Jun N-Terminal Kinase Mediates Tumor Necrosis Factor-{alpha} Suppression of Differentiation in Myoblasts
Endocrinology, September 1, 2006; 147(9): 4363 - 4373.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. J. Berkley, S. S. Zalcman, and V. R. Simon
Sex and gender differences in pain and inflammation: a rapidly maturing field
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R241 - R244.
[Full Text] [PDF]


Home page
J EndocrinolHome page
V E MacRae, C Farquharson, and S F Ahmed
The restricted potential for recovery of growth plate chondrogenesis and longitudinal bone growth following exposure to pro-inflammatory cytokines.
J. Endocrinol., May 1, 2006; 189(2): 319 - 328.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
V. E. MacRae, C. Farquharson, and S. F. Ahmed
The pathophysiology of the growth plate in juvenile idiopathic arthritis
Rheumatology, January 1, 2006; 45(1): 11 - 19.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Strle, S. R. Broussard, R. H. McCusker, W.-H. Shen, R. W. Johnson, G. G. Freund, R. Dantzer, and K. W. Kelley
Proinflammatory Cytokine Impairment of Insulin-Like Growth Factor I-Induced Protein Synthesis in Skeletal Muscle Myoblasts Requires Ceramide
Endocrinology, October 1, 2004; 145(10): 4592 - 4602.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.